- Lee, J;
- Zeng, J;
- Hughes, G;
- Chen, Y;
- Grob, S;
- Zhao, L;
- Lee, C;
- Krupa, M;
- Quach, J;
- Luo, J;
- Zeng, J;
- Wei, X;
- Zhang, X;
- Zhu, J;
- Duan, Y;
- Ferreyra, H;
- Goldbaum, M;
- Haw, W;
- Shaw, PX;
- Tang, L;
- Zhang, K
Purpose
To determine whether there is an association between hepatic lipase (LIPC) and age-related macular degeneration (AMD) in two independent Caucasian cohorts.Methods
A discovery cohort of 1626 patients with advanced AMD and 859 normal controls and a replication cohort of 2159 cases and 1150 controls were genotyped for two single-nucleotide polymorphisms (SNPs) in the promoter region of LIPC. The associations between the SNPs and AMD were examined by χ(2) tests.Results
In the discovery cohort, rs493258 and rs10468017 were both associated with advanced AMD (P=9.63E-3 and P=0.048, respectively). The association was corroborated in the replication cohort (P=4.48E-03 for rs493258 and P=0.015 for rs10468017). Combined analysis resulted in even more significant associations (P=1.21E-04 for rs493258 and P=1.67E-03 for rs10468017).Conclusion
The LIPC promoter variants rs493258 and rs10468017 were associated with advanced AMD in two independent Caucasian populations, confirming that LIPC polymorphisms may be a genetic risk factor for AMD in the Caucasian population.